Human psittacosis cured by penicillin therapy

California Medicine
|March 1, 1949
PubMed

Insights

Penicillin can effectively treat psittacosis if administered early and in sufficient doses. Inadequate or delayed penicillin treatment shows no benefit for this bird-borne illness.

Area of Science:

  • Infectious Diseases
  • Virology
  • Pharmacology

Background:

  • Psittacosis is a zoonotic infection caused by Chlamydia psittaci.
  • Recent literature suggests penicillin's efficacy in treating human psittacosis.
  • Efficacy is dependent on early and adequate dosing, particularly in experimentally induced infections.

Purpose of the Study:

  • To analyze the effectiveness of penicillin in treating psittacosis.
  • To highlight the importance of early diagnosis and appropriate penicillin dosage.
  • To consider psittacosis as a differential diagnosis for atypical pneumonia, especially with avian exposure.

Main Methods:

  • Review of literature on penicillin treatment for psittacosis.
  • Case report of a patient with suspected psittacosis following bird contact.
  • Comparison of treatment outcomes with different penicillin dosages.

Main Results:

  • Penicillin showed no benefit at 100,000 units every three hours for one day in a reported case.
  • Doubling the penicillin dose led to rapid recovery in the same patient.
  • Experimental studies show success with large penicillin doses in early stages.

Conclusions:

  • Early and high-dose penicillin therapy is crucial for successful psittacosis treatment.
  • Atypical pneumonia cases with potential bird exposure warrant investigation for psittacosis.
  • Inadequate or delayed penicillin administration may lead to treatment failure.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...